In the first five calls, 16 different projects were selected for funding. A dedicated COVID-19 call was launched during the COVID-19 crisis, which resulted in co-funding of 3 COVID-specific projects.
The SOY 2.0 project aims to boost sustainable soybean cultivation in Belgium by matching the best local soybean varieties with native nitrogen-fixing bacteria from Flemish soils.
The BE.Amycon aims to establish a Belgian center of expertise for people with peripheral amyloidosis by joining forces of VIB researchers, a state-of-the-art diagnostic platform, and clinicians from various disciplines and different institutes.
Catching nitrogen-fixing bacteria (Rhizobia) to introduce high protein-containing soybean for a sustainable agriculture in Flanders in the Soy project.
Developing a platform to find nanobody constructs that can cross the blood-brain barrier, as a way of treating brain diseases in the blood-brain-barrier (BBB) project.
Inducing drug-free remission in spondyloarthritis patients by early treatment with biologicals under guidance of single-cell and epigenetic profiling in the Spartacus project.
Improving treatment outcome prediction by characterizing the tumor and tumor micro-environment at single-cell level during treatment with immune-checkpoint blockers in the Pointillism project.
Improving our understanding and diagnosis of life-threatening genetic disorders of the innate and adaptive immune system in the primary immune deficiency (PID) project.
